Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant
Clinical trial NCT03625687 · TERMINATED
Trial details
- NCT number
- NCT03625687
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2022-04-04
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.